SITC annual meeting 2022
Efficacy study of STC-1010 antitumor vaccine associated with standard chemotherapies on MC 38 syngeneic colon cancer tumor model F. Ghiringhelli et al, Journal for ImmunoTherapy of Cancer 2022; 1179 doi: 10.1136/jitc-2022-SITC2022.1179 Link to poster Inovative in vivo (in ovo) cam model to predict efficacy and mode of action of a new antitumor vaccine stc-1010 on human colorectal adenocarcinoma F. Ghiringhelli et al, Journal for ImmunoTherapy of Cancer 2022; 949 http://dx.doi.org/10.1136/jitc-2022-SITC2022.0949 Link to Poster
AACR annual meeting 2022
Sensitizing potential of a novel stimulated and haptenized vaccine in immunotherapy resistant metastatic colorectal cancer R. Boidot et al, Cancer Res 2022; 3566. https://doi.org/10.1158/1538-7445.AM2022-3566 Link to Poster Antitumor activity of a novel allogeneic colorectal cancer vaccine in C57BL/6 mice bearing MC38 anti-PD1 resistant colon carcinoma syngeneic model with TME A. Italiano et al, Cancer Res 2022; 2051. https://doi.org/10.1158/1538-7445.AM2022-2051 Link to Poster
AACR 2021 Annual Conference
Efficacy results of a novel vaccine composed of stimulated and haptenized tumors cells in Balbc mice grafted with murine colon adenocarcinoma CT26 cells C. Gongora et al, Cancer Immunol Res 2022; P003. https://doi.org/10.1158/2326-6074.TUMIMM21-P003 Link to PDF presentation